These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34587978)

  • 21. Activation of PLCβ1 enhances endocannabinoid mobilization to restore hippocampal spike-timing-dependent potentiation and contextual fear memory impaired by Alzheimer's amyloidosis.
    Lee J; Kwag J
    Alzheimers Res Ther; 2021 Oct; 13(1):165. PubMed ID: 34625112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
    Kimura R; Devi L; Ohno M
    J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
    Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
    Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
    Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
    Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model.
    Smith LA; McMahon LL
    Neurobiol Dis; 2018 Feb; 110():166-179. PubMed ID: 29199135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer's disease.
    Du Y; Fu M; Huang Z; Tian X; Li J; Pang Y; Song W; Tian Wang Y; Dong Z
    Aging Cell; 2020 Mar; 19(3):e13113. PubMed ID: 32061032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
    Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S
    J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered synaptic plasticity at hippocampal CA1-CA3 synapses in Alzheimer's disease: integration of amyloid precursor protein intracellular domain and amyloid beta effects into computational models.
    Dainauskas JJ; Vitale P; Moreno S; Marie H; Migliore M; Saudargiene A
    Front Comput Neurosci; 2023; 17():1305169. PubMed ID: 38130706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PGE
    Maingret V; Barthet G; Deforges S; Jiang N; Mulle C; Amédée T
    Neurobiol Aging; 2017 Feb; 50():13-24. PubMed ID: 27837675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1δE9-deleted transgenic mice model of ß-amyloidosis.
    Volianskis A; Køstner R; Mølgaard M; Hass S; Jensen MS
    Neurobiol Aging; 2010 Jul; 31(7):1173-87. PubMed ID: 18790549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of blunting astrocyte activity on hippocampal synaptic plasticity in a mouse model of early Alzheimer's disease based on amyloid-β peptide exposure.
    Lopes CR; Amaral IM; Pereira MF; Lopes JP; Madeira D; Canas PM; Cunha RA; Agostinho P
    J Neurochem; 2022 Mar; 160(5):556-567. PubMed ID: 35043392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strain differences in hippocampal synaptic dysfunction in the TgCRND8 mouse model of Alzheimer's disease: Implications for improving translational capacity.
    Snow WM; Oikawa K; Djordjevic J; Albensi BC
    Mol Cell Neurosci; 2019 Jan; 94():11-22. PubMed ID: 30404024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.
    Benito C; Tolón RM; Castillo AI; Ruiz-Valdepeñas L; Martínez-Orgado JA; Fernández-Sánchez FJ; Vázquez C; Cravatt BF; Romero J
    Br J Pharmacol; 2012 Jun; 166(4):1474-89. PubMed ID: 22321194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
    Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
    Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal p38α mediates synaptic and cognitive dysfunction in an Alzheimer's mouse model by controlling β-amyloid production.
    Colié S; Sarroca S; Palenzuela R; Garcia I; Matheu A; Corpas R; Dotti CG; Esteban JA; Sanfeliu C; Nebreda AR
    Sci Rep; 2017 Mar; 7():45306. PubMed ID: 28361984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid Accumulation.
    Yao J; Sun B; Institoris A; Zhan X; Guo W; Song Z; Liu Y; Hiess F; Boyce AKJ; Ni M; Wang R; Ter Keurs H; Back TG; Fill M; Thompson RJ; Turner RW; Gordon GR; Chen SRW
    Cell Rep; 2020 Sep; 32(12):108169. PubMed ID: 32966798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer's disease neuropathology.
    Chen F; Swartzlander DB; Ghosh A; Fryer JD; Wang B; Zheng H
    Mol Neurodegener; 2021 Jan; 16(1):5. PubMed ID: 33517893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
    Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
    Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease.
    Pilat D; Paumier JM; García-González L; Louis L; Stephan D; Manrique C; Khrestchatisky M; Di Pasquale E; Baranger K; Rivera S
    J Neuroinflammation; 2022 Mar; 19(1):65. PubMed ID: 35277173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.